Page 81

/ 81 miology, human pharmacology, and treatment. a perspective on a new debut for an old girl”. Clin. Toxicol. 8 (2): 149–78. 64. G. Barnett, R. Hawks and R. Resnick, “Cocaine Pharmacokinetics in Humans,” 3 Journal of Ethnopharmacology 353 (1981); 65. Gold MS. Cocaine (and crack): clinical aspects. In: Lowinson JH, et al, eds. Substance Abuse: A Comprehensive Text . 2 nd ed. Lippincott Williams & Wilkins: Baltimore, Md; 1992. 66. Godfrey, M. Heroin. Gloucester Press, London, 1987. Goran ilić, Radovan Karadžić, Lidija Kostić-Banović, Jovan Stojanović. Chronic intravenous heroin abuse: impact on the liver. Medicine and biology vol.12, no 3, 2005, pp. 150 - 153 67. Grund, J-P. From the Straw to the Needle? Determinants of Heroin Administration Routed. In: Heroin in the Age of Crack-Cocaine, 215-258. Hall W, Babor TF. Cannabis use and public health: assessing the burden. Addiction. 2000;95:485-490. 69. Hayase T, Yamamoto Y, Yamamoto K (1999). „Role of cocaethylene in toxic symptoms due to repeated subcutaneous cocaine administration modified by oral doses of ethanol”. J Toxicol Sci 24 (3): 227–35. PMID 10478337. 70. Hilts, Philip J. (1994). Relative Addictiveness of Drugs. New York Times. 71. Hilber B, Scholze P, Dorostkar MM (November 2005). „Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines”. Neuropharmacology 49 (6): 811–9. doi:10.1016/j.neuropharm.2005.08.00 8. PMID 16185723. 72. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Neuroscience of Drug Abuse Program, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, North Carolina, USA. 73.

Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med . Jul-Aug 1994;1(4):330-9. [Medline] .

74. Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med . Mar-Apr 1992;10(2):169-77. [Medline] . 75. Hollander JE, Hoffman RS, Burstein JL, Shih RD, Thode HC Jr.  Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group.  Arch Intern Med 1995 May 22;155(10):1081-6. 76. Huestis M, Henningfield J, Cone E. Blood cannabinoids. I. Absorption of THC and Formation of 11-OH-THC and THCCOOH during and after smoking Marijuana. J Analyt Toxicol 1992;16: 276-82. [PubMed] 77. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH) Journal of Analytical Toxicology. 1992 Sep-Oct;16(5):283-90. PMID 1338216

Aleksandaraleksandrov sadebna medicina aspekti pri smartni sluchai na lica s danni za upotreba na na  
Aleksandaraleksandrov sadebna medicina aspekti pri smartni sluchai na lica s danni za upotreba na na  

Александър Алексанров Съдебна медицина 2013 Aleksander Aleksandrov Forensic Medicine 2013